PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.
days to go:
Expired
investment:
£144,265
Cranes Drinks is the fastest growing cider company in the UK, producing a range of innovative fruit ciders. By utilising the fruit’s natural sweetness, its drinks contain 30% fewer calories compared to that of brand leaders. Cranes ciders come in 3 flavours: blueberry & apple, cranberry & lime, and raspberry & pomegranate. As per Cranes, 34% of cider drinkers haven't consumed cider drinks much because it’s too sweet or has too much sugar. This makes Cranes a top contender in a growing fruit cider market worth £1.3 billion. The company's entire range is available on Ocado, and it has received 3 national listings in prominent retail chains like Sainsbury’s, Asda, and Morrisons. The brand has won 3 awards for its spirit range including a Gold Award in the Liqueur Masters organised by The Spirits Business and two awards from the International Wine & Spirits Competition. It has also received substantial media coverage in publications like Made In Chelsea, Dragons Dens, The Daily Telegraph, The Evening Standard, Vogue, Cosmopolitan, and Bella amongst others. With the investment, the company aims to use 25% of it as working capital, 60% in marketing, and 15% in managing key finances.
days to go:
Expired
investment:
£246,046
Myn is an innovative source-to-pay platform driven by AI, aiming to establish a seamless network connecting companies, workers, and recruiters. Their end-to-end solution encompasses intelligent talent sourcing, self-service talent acquisition, fully funded payrolling services, digital compliance solutions, job boards, and enticing employee benefits.
days to go:
Expired
investment:
£939,520
Muse is a smart, data-driven financial management application which aims to make financial empowerment a reality for all business owners. The app generates clear snapshots of a company’s finances showing all bank balances, and gives quick access to innovative invoice financing and other smart tools. Muse is live on the App Store and Google Play. Moreover, it has partnered with Prime 5 Finance Limited for invoice finance facility. The funds raised will be used to expand the business, sales channels and give an e-money account card in three currencies.
days to go:
Expired
investment:
£339,920
Chip is one of the fastest-growing Fintech companies in the UK. Chip has built an app that uses the user's banking app to make personalised decisions about their money. Its user base has doubled since its previous fundraising in 2018. The company has 153,000 accounts, and it has processed more than £130m of savings. ChipX is the company's revolutionary returns platform and it has a waiting list of more than 50,000 people. The company is a winner of the British Bank Award, 2 Crowdcube awards, and 1 World Banking Award. It has welcomed many management executives from Funding Circle, Monzo, and Purple Bricks. Chip is now scaling with market-leading returns on ChipX. It aims to build the biggest savings account in the world. With the proceeds, the company will double its team and expand ChipX in the €10 trillion European savings market.
days to go:
Expired
investment:
£3,768,260
Verado is a data-driven and scalable proprietary platform that aims to eradicate counterfeits within the watch & jewelry industry. It enables private sellers to sell their luxury watches autonomously online. Verado analyzes thousands of similar items across the internet and gives the fairest price for both buyers and sellers. By adding verification, authentication and financial escrow, Verado is solving a basic problem associated with buying and selling fine jewelry. In a market with zero transparency, Verado is able to provide a community for collectors, sellers, and buyers. The platform has the security and personality of old school selling with the reach and speed of an online platform. The company has achieved €400,000+ sales and 10,000 cellular listings onto the platform. Verado has been featured in many publications like watchuseek, Forbes, and Buzzfeed. With the proceeds, the company is planning to build awareness and build upon its growing community.
days to go:
Expired
investment:
£37,270
